Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Abortion, Habitual D000026 5 associated lipids
Acidosis D000138 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Agranulocytosis D000380 7 associated lipids
Airway Obstruction D000402 13 associated lipids
Albuminuria D000419 18 associated lipids
Alcoholic Intoxication D000435 15 associated lipids
Anaphylaxis D000707 35 associated lipids
Anemia D000740 21 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
DeVries A et al. Ketoconazole in the prevention of acute respiratory distress syndrome. 1998 May-Jun Pharmacotherapy pmid:9620108
Tsai WJ et al. Characterization of the antiplatelet effects of (2S)-5-methoxy-6-methylflavan-7-ol from Draconis Resina. 1998 Eur. J. Pharmacol. pmid:9617759
Agnoli GC et al. Effects of experimental salt depletion on urinary prostanoid excretions in normal women. 1998 Prostaglandins Leukot. Essent. Fatty Acids pmid:9610848
Beitz A Influence of diet-modified lipoprotein fractions from rabbits on eicosanoid production and on proliferation of rabbit skin fibroblasts. 1998 Prostaglandins Leukot. Essent. Fatty Acids pmid:9610847
van der Weiden RM et al. Which prostanoid metabolites should be determined for the study of reproductive processes? 1998 Prostaglandins Leukot. Essent. Fatty Acids pmid:9610843
Cignarella A et al. Platelet activation supports the development of venous thrombosis in hyperlipidemic rats. 1998 Blood Coagul. Fibrinolysis pmid:9607118
Komarevtseva IA et al. [Change in prostanoid metabolism in cystic kidney lesion]. 1997 Sep-Dec Ukr. Biokhim. Zh. pmid:9606841
Heller DA et al. Mortality and biomarkers of aging in heterogeneous stock (HS) mice. 1998 J. Gerontol. A Biol. Sci. Med. Sci. pmid:9597046
Kalgutkar AS et al. Aspirin-like molecules that covalently inactivate cyclooxygenase-2. 1998 Science pmid:9596581
Inoue H et al. Changes in endothelin-1, 6-keto-PG-F1 alpha, and TX-B2 in random pattern flaps. 1998 J. Cardiovasc. Pharmacol. pmid:9595517
Stamler A et al. Low-dose dopexamine's effect on lung and gut function after CPB in a sheep model. 1998 J. Surg. Res. pmid:9587356
Fuse S et al. Plasma thromboxane B2 concentration in patients with ventricular septal defect and pulmonary hypertension. 1998 Jpn. Circ. J. pmid:9583446
Failli P et al. Effect of some cyclooxygenase inhibitors on the increase in guanosine 3':5'-cyclic monophosphate induced by NO-donors in human whole platelets. 1998 Br. J. Pharmacol. pmid:9579743
Kosugi T et al. Glomerular thromboxane contributes to pressor response in deoxycorticosterone acetate-salt hypertension. 1998 Prostaglandins Leukot. Essent. Fatty Acids pmid:9578151
Davì G et al. Increased thromboxane metabolites excretion in liver cirrhosis. 1998 Thromb. Haemost. pmid:9569186
Muscará MN et al. Effect of a nitric oxide-releasing naproxen derivative on hypertension and gastric damage induced by chronic nitric oxide inhibition in the rat. 1998 Life Sci. pmid:9566780
Darien BJ et al. Low molecular weight heparin prevents the pulmonary hemodynamic and pathomorphologic effects of endotoxin in a porcine acute lung injury model. 1998 Shock pmid:9565256
LaNoue JL et al. Alveolar macrophage response to remote organ injury. 1998 Shock pmid:9565254
Yang VW et al. Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis. 1998 Cancer Res. pmid:9563494
Arbogast E et al. Intrauterine eicosanoid production in uncomplicated and hypertensive pregnancies: alterations of placental 12-hydroxyeicosatetraenoic acid. 1997 Adv. Exp. Med. Biol. pmid:9561182
Müller M In vivo measurement of interstitial TxB2-concentrations in skeletal muscle during ischemia and reperfusion. 1997 Adv. Exp. Med. Biol. pmid:9561122
Yoshida T et al. Improvement of renal function with selective thromboxane A2 synthetase inhibitor, DP-1904 in lupus nephritis. 1997 Adv. Exp. Med. Biol. pmid:9561116
Agostoni C et al. Plasma arachidonic acid and serum thromboxane B2 concentrations in phenylketonuric children are correlated with dietary compliance. 1998 Z Ernahrungswiss pmid:9558743
Vormann J et al. Pathobiochemical effects of graded magnesium deficiency in rats. 1998 Z Ernahrungswiss pmid:9558736
van den Dorpel MA et al. Forearm vasorelaxation in hypertensive renal transplant patients: the impact of withdrawal of cyclosporine. 1998 J. Hypertens. pmid:9557926
Naran NH and Chetty N The in vitro effect of ridogrel on platelet function in normocholesterolaemic and familial hypercholesterolaemic type IIa subjects. 1997 Thromb. Res. pmid:9556227
Mayser P et al. Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, multicenter trial. 1998 J. Am. Acad. Dermatol. pmid:9555791
Kimura H et al. Compensatory excretion of prostacyclin and thromboxane metabolites in obstructive sleep apnea syndrome. 1998 Intern. Med. pmid:9550591
Suchkova V Prostanoid and anti-thrombin III levels in premature infants. 1997 Adv. Exp. Med. Biol. pmid:9547655
Liao CH et al. Effect of PP1D-1, a synthetic antiplatelet compound, on rabbit platelets. 1998 Jpn. J. Pharmacol. pmid:9541276
Herrera JA et al. Prevention of preeclampsia by linoleic acid and calcium supplementation: a randomized controlled trial. 1998 Obstet Gynecol pmid:9540946
Zhao Y et al. Urinary thromboxane B2 in cardiac transplant patients as a screening method of rejection. 1997 Prostaglandins pmid:9533183
Fukushima C et al. Effect of synthetase inhibitors and receptor antagonists in antigen-induced contraction of human lung parenchyma. 1998 Ann. Allergy Asthma Immunol. pmid:9532973
Diven WF et al. Expression of acute otitis media after receptor blockade of platelet activating factor, thromboxane, and leukotrienes in the chinchilla. 1998 Ann. Otol. Rhinol. Laryngol. pmid:9525240
Bons-Sicard C et al. Localization and quantification of TXB2 in human healthy and inflammatory gingival mucosa. 1998 J. Periodont. Res. pmid:9524318
Ooi BS et al. Stimulation of endothelial cell production of vasoconstrictive substances by hypertensive sera. 1998 Am. J. Hypertens. pmid:9524055
Bode-Böger SM et al. Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitro. 1998 Naunyn Schmiedebergs Arch. Pharmacol. pmid:9521487
Giustina A et al. Long-term treatment with the dual antithromboxane agent picotamide decreases microalbuminuria in normotensive type 2 diabetic patients. 1998 Diabetes pmid:9519749
Rho MC et al. Two distinct effects of 12S-hydroxyeicosatetraenoic acid on platelet aggregation by zooxanthellatoxin-A and ionomycin. 1998 Jpn. J. Pharmacol. pmid:9517414
Larsen LN et al. Alpha- and beta- alkyl-substituted eicosapentaenoic acids: incorporation into phospholipids and effects on prostaglandin H synthase and 5-lipoxygenase. 1998 Biochem. Pharmacol. pmid:9514074
Giardiello FM et al. Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposis. 1998 Dig. Dis. Sci. pmid:9512123
Schilling MK et al. Role of thromboxane and leukotriene B4 in patients with acute respiratory distress syndrome after oesophagectomy. 1998 Br J Anaesth pmid:9505775
Dschietzig T et al. Coronary constriction and consequent cardiodepression in pulmonary embolism are mediated by pulmonary big endothelin and enhanced in early endothelial dysfunction. 1998 Crit. Care Med. pmid:9504580
Bernareggi M et al. Bronchopulmonary effects of 8-epi-PGF2A in anaesthetised guinea pigs. 1998 Pharmacol. Res. pmid:9503483
Bagdasarian A et al. IVIG adverse reactions: potential role of cytokines and vasoactive substances. 1998 Vox Sang. pmid:9501404
Turner NC et al. Elevated renal endothelin-I clearance and mRNA levels associated with albuminuria and nephropathy in non-insulin-dependent diabetes mellitus: studies in obese fa/fa Zucker rats. 1997 Clin. Sci. pmid:9497794
Takakuwa K et al. Immunosuppressive therapy for recurrent aborters with positive antiphospholipid antibodies and alteration of 6ketoPGF1 alpha/TXB2 ratio. 1997 J Perinat Med pmid:9494925
Takeda H et al. Time course study for airway inflammation and responsiveness by repeated provocation of aeroantigen in guinea pigs. 1997 Prostaglandins pmid:9491210
Provost P et al. Platelets, neutrophils, and vasoconstriction after arterial injury by angioplasty in pigs: effects of MK-886, a leukotriene biosynthesis inhibitor. 1998 Br. J. Pharmacol. pmid:9489613
Nieuwenhuys CM and Hornstra G The effects of purified eicosapentaenoic and docosahexaenoic acids on arterial thrombosis tendency and platelet function in rats. 1998 Biochim. Biophys. Acta pmid:9487152